Latest Updates
May 2008 Combination Trial Updates and Additions

Protocol ID	Trial Title
CDR0000302482; CALGB-10102; NCT00061945	Phase I/II Study of Alemtuzumab During Post-Remission Intensification Therapy in Patients With Untreated Acute Lymphoblastic Leukemia (Phase I Portion Closed to Accrual as of 7/5/2005)
CDR0000466109; MSGCC-GCC-0514; NCI-6835; NCT00310024	A Phase I Study of SAHA in Combination With Bortezomib in Relapsed and Refractory Multiple Myeloma